nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinonide—SMO—brain cancer	0.836	1	CbGaD
Fluocinonide—SMO—Hedgehog Signaling Pathway—PTCH2—brain cancer	0.00893	0.0839	CbGpPWpGaD
Fluocinonide—SMO—Hedgehog Signaling Pathway—GLI2—brain cancer	0.00677	0.0636	CbGpPWpGaD
Fluocinonide—SMO—Signaling events mediated by the Hedgehog family—PTCH2—brain cancer	0.00668	0.0628	CbGpPWpGaD
Fluocinonide—SMO—Hedgehog Signaling Pathway—GLI1—brain cancer	0.00636	0.0598	CbGpPWpGaD
Fluocinonide—SMO—Hedgehog Signaling Pathway—SUFU—brain cancer	0.00603	0.0567	CbGpPWpGaD
Fluocinonide—SMO—Signaling events mediated by the Hedgehog family—GLI2—brain cancer	0.00506	0.0476	CbGpPWpGaD
Fluocinonide—SMO—Hedgehog Signaling Pathway—SHH—brain cancer	0.0046	0.0432	CbGpPWpGaD
Fluocinonide—SMO—Hedgehog Signaling Pathway—PTCH1—brain cancer	0.00436	0.041	CbGpPWpGaD
Fluocinonide—Condition aggravated—Temozolomide—brain cancer	0.0037	0.114	CcSEcCtD
Fluocinonide—SMO—Signaling events mediated by the Hedgehog family—SHH—brain cancer	0.00344	0.0323	CbGpPWpGaD
Fluocinonide—SMO—Signaling events mediated by the Hedgehog family—PTCH1—brain cancer	0.00326	0.0306	CbGpPWpGaD
Fluocinonide—Cushing's syndrome—Carmustine—brain cancer	0.00308	0.0951	CcSEcCtD
Fluocinonide—Skin atrophy—Hydroxyurea—brain cancer	0.00287	0.0884	CcSEcCtD
Fluocinonide—SMO—Hedgehog signaling events mediated by Gli proteins—GLI2—brain cancer	0.00281	0.0264	CbGpPWpGaD
Fluocinonide—Atrophy—Hydroxyurea—brain cancer	0.00266	0.0819	CcSEcCtD
Fluocinonide—SMO—Hedgehog signaling events mediated by Gli proteins—GLI1—brain cancer	0.00264	0.0248	CbGpPWpGaD
Fluocinonide—SMO—Hedgehog signaling events mediated by Gli proteins—SUFU—brain cancer	0.00251	0.0235	CbGpPWpGaD
Fluocinonide—SERPINA6—hindbrain—brain cancer	0.0024	0.0939	CbGeAlD
Fluocinonide—SMO—Class B/2 (Secretin family receptors)—PTCH2—brain cancer	0.0023	0.0216	CbGpPWpGaD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—SHH—brain cancer	0.00213	0.02	CbGpPWpGaD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—PTCH1—brain cancer	0.00202	0.0189	CbGpPWpGaD
Fluocinonide—SMO—Hedgehog signaling events mediated by Gli proteins—SHH—brain cancer	0.00191	0.0179	CbGpPWpGaD
Fluocinonide—SMO—Hedgehog signaling events mediated by Gli proteins—PTCH1—brain cancer	0.00181	0.017	CbGpPWpGaD
Fluocinonide—SMO—pituitary gland—brain cancer	0.00181	0.0706	CbGeAlD
Fluocinonide—SMO—medulla oblongata—brain cancer	0.00174	0.0681	CbGeAlD
Fluocinonide—SMO—midbrain—brain cancer	0.00159	0.0623	CbGeAlD
Fluocinonide—SMO—Hedgehog 'off' state—GLI2—brain cancer	0.00159	0.0149	CbGpPWpGaD
Fluocinonide—SMO—spinal cord—brain cancer	0.00155	0.0607	CbGeAlD
Fluocinonide—SMO—Hedgehog 'off' state—GLI1—brain cancer	0.00149	0.014	CbGpPWpGaD
Fluocinonide—SMO—Signaling by Hedgehog—GLI2—brain cancer	0.00142	0.0133	CbGpPWpGaD
Fluocinonide—SMO—Hedgehog 'off' state—SUFU—brain cancer	0.00142	0.0133	CbGpPWpGaD
Fluocinonide—Eruption—Hydroxyurea—brain cancer	0.00141	0.0434	CcSEcCtD
Fluocinonide—SMO—endocrine gland—brain cancer	0.0014	0.0547	CbGeAlD
Fluocinonide—SMO—head—brain cancer	0.00138	0.054	CbGeAlD
Fluocinonide—SMO—Signaling by Hedgehog—GLI1—brain cancer	0.00133	0.0125	CbGpPWpGaD
Fluocinonide—SMO—Signaling by Hedgehog—SUFU—brain cancer	0.00126	0.0119	CbGpPWpGaD
Fluocinonide—SMO—central nervous system—brain cancer	0.00126	0.0493	CbGeAlD
Fluocinonide—NR3C1—Endoderm Differentiation—OTX2—brain cancer	0.00123	0.0116	CbGpPWpGaD
Fluocinonide—SMO—cerebellum—brain cancer	0.00123	0.0482	CbGeAlD
Fluocinonide—SMO—Class B/2 (Secretin family receptors)—SHH—brain cancer	0.00119	0.0112	CbGpPWpGaD
Fluocinonide—SMO—Class B/2 (Secretin family receptors)—PTCH1—brain cancer	0.00113	0.0106	CbGpPWpGaD
Fluocinonide—NR3C1—hindbrain—brain cancer	0.00105	0.0411	CbGeAlD
Fluocinonide—SMO—Hedgehog 'off' state—PTCH1—brain cancer	0.00102	0.00961	CbGpPWpGaD
Fluocinonide—SMO—brain—brain cancer	0.001	0.0391	CbGeAlD
Fluocinonide—SERPINA6—pituitary gland—brain cancer	0.000995	0.0389	CbGeAlD
Fluocinonide—SMO—Signaling by Hedgehog—SHH—brain cancer	0.000963	0.00905	CbGpPWpGaD
Fluocinonide—SMO—Signaling by Hedgehog—PTCH1—brain cancer	0.000913	0.00858	CbGpPWpGaD
Fluocinonide—Skin exfoliation—Hydroxyurea—brain cancer	0.000827	0.0255	CcSEcCtD
Fluocinonide—SERPINA6—endocrine gland—brain cancer	0.00077	0.0301	CbGeAlD
Fluocinonide—SERPINA6—head—brain cancer	0.000761	0.0297	CbGeAlD
Fluocinonide—Infection—Carboplatin—brain cancer	0.000714	0.022	CcSEcCtD
Fluocinonide—SERPINA6—central nervous system—brain cancer	0.000694	0.0271	CbGeAlD
Fluocinonide—SERPINA6—cerebellum—brain cancer	0.000679	0.0265	CbGeAlD
Fluocinonide—Skin exfoliation—Carmustine—brain cancer	0.000668	0.0206	CcSEcCtD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—CTNNB1—brain cancer	0.000662	0.00622	CbGpPWpGaD
Fluocinonide—Skin exfoliation—Temozolomide—brain cancer	0.000646	0.0199	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000633	0.00594	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—PTCH2—brain cancer	0.00063	0.00592	CbGpPWpGaD
Fluocinonide—Infection—Lomustine—brain cancer	0.000624	0.0193	CcSEcCtD
Fluocinonide—Pain—Carboplatin—brain cancer	0.000614	0.019	CcSEcCtD
Fluocinonide—NR3C1—brainstem—brain cancer	0.000603	0.0236	CbGeAlD
Fluocinonide—Swelling—Carmustine—brain cancer	0.000576	0.0178	CcSEcCtD
Fluocinonide—SERPINA6—brain—brain cancer	0.000551	0.0215	CbGeAlD
Fluocinonide—Nasal congestion—Temozolomide—brain cancer	0.000539	0.0166	CcSEcCtD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—MYC—brain cancer	0.000537	0.00504	CbGpPWpGaD
Fluocinonide—NR3C1—telencephalon—brain cancer	0.000535	0.0209	CbGeAlD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—brain cancer	0.000525	0.00493	CbGpPWpGaD
Fluocinonide—Skin exfoliation—Etoposide—brain cancer	0.000517	0.0159	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000506	0.00476	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—OR4C12—brain cancer	0.000502	0.00471	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—OR14C36—brain cancer	0.000502	0.00471	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—IRS2—brain cancer	0.000468	0.0044	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptors—ESR2—brain cancer	0.000466	0.00437	CbGpPWpGaD
Fluocinonide—Dry skin—Temozolomide—brain cancer	0.00045	0.0139	CcSEcCtD
Fluocinonide—NR3C1—gonad—brain cancer	0.000446	0.0175	CbGeAlD
Fluocinonide—Swelling—Etoposide—brain cancer	0.000445	0.0137	CcSEcCtD
Fluocinonide—NR3C1—pituitary gland—brain cancer	0.000436	0.017	CbGeAlD
Fluocinonide—NR3C1—medulla oblongata—brain cancer	0.00042	0.0164	CbGeAlD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000416	0.00391	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000408	0.00383	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000403	0.00378	CbGpPWpGaD
Fluocinonide—Infection—Procarbazine—brain cancer	0.000396	0.0122	CcSEcCtD
Fluocinonide—Hyperglycaemia—Carmustine—brain cancer	0.000396	0.0122	CcSEcCtD
Fluocinonide—NR3C1—midbrain—brain cancer	0.000384	0.015	CbGeAlD
Fluocinonide—Hyperglycaemia—Temozolomide—brain cancer	0.000383	0.0118	CcSEcCtD
Fluocinonide—Erythema—Hydroxyurea—brain cancer	0.000378	0.0117	CcSEcCtD
Fluocinonide—NR3C1—spinal cord—brain cancer	0.000375	0.0147	CbGeAlD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000374	0.00352	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000368	0.00346	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000357	0.00335	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HES5—brain cancer	0.000353	0.00332	CbGpPWpGaD
Fluocinonide—Pain—Procarbazine—brain cancer	0.000341	0.0105	CcSEcCtD
Fluocinonide—NR3C1—endocrine gland—brain cancer	0.000337	0.0132	CbGeAlD
Fluocinonide—NR3C1—head—brain cancer	0.000333	0.013	CbGeAlD
Fluocinonide—SMO—GPCR ligand binding—SHH—brain cancer	0.000325	0.00305	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PTCH2—brain cancer	0.000323	0.00304	CbGpPWpGaD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00032	0.00987	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000308	0.0029	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—PTCH1—brain cancer	0.000308	0.00289	CbGpPWpGaD
Fluocinonide—Infection—Hydroxyurea—brain cancer	0.000307	0.00947	CcSEcCtD
Fluocinonide—Immune system disorder—Temozolomide—brain cancer	0.000307	0.00946	CcSEcCtD
Fluocinonide—Erythema—Carmustine—brain cancer	0.000306	0.00944	CcSEcCtD
Fluocinonide—NR3C1—central nervous system—brain cancer	0.000304	0.0119	CbGeAlD
Fluocinonide—Nervous system disorder—Hydroxyurea—brain cancer	0.000303	0.00934	CcSEcCtD
Fluocinonide—Skin disorder—Hydroxyurea—brain cancer	0.0003	0.00925	CcSEcCtD
Fluocinonide—NR3C1—cerebellum—brain cancer	0.000297	0.0116	CbGeAlD
Fluocinonide—SMO—Signaling Pathways—OR14C36—brain cancer	0.000296	0.00278	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—OR4C12—brain cancer	0.000296	0.00278	CbGpPWpGaD
Fluocinonide—Erythema—Temozolomide—brain cancer	0.000296	0.00912	CcSEcCtD
Fluocinonide—Hypersensitivity—Procarbazine—brain cancer	0.000294	0.00907	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.00029	0.00273	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.000287	0.0027	CbGpPWpGaD
Fluocinonide—Pruritus—Procarbazine—brain cancer	0.000282	0.00871	CcSEcCtD
Fluocinonide—Pain—Hydroxyurea—brain cancer	0.000264	0.00815	CcSEcCtD
Fluocinonide—Dizziness—Procarbazine—brain cancer	0.000264	0.00814	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—ABR—brain cancer	0.000254	0.00238	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—DTX2—brain cancer	0.000252	0.00237	CbGpPWpGaD
Fluocinonide—Rash—Procarbazine—brain cancer	0.000252	0.00776	CcSEcCtD
Fluocinonide—Dermatitis—Procarbazine—brain cancer	0.000251	0.00776	CcSEcCtD
Fluocinonide—Headache—Procarbazine—brain cancer	0.00025	0.00771	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00025	0.00771	CcSEcCtD
Fluocinonide—Infection—Carmustine—brain cancer	0.000248	0.00765	CcSEcCtD
Fluocinonide—Immune system disorder—Etoposide—brain cancer	0.000245	0.00757	CcSEcCtD
Fluocinonide—NR3C1—brain—brain cancer	0.000241	0.00944	CbGeAlD
Fluocinonide—Infection—Temozolomide—brain cancer	0.00024	0.00739	CcSEcCtD
Fluocinonide—Nervous system disorder—Temozolomide—brain cancer	0.000237	0.0073	CcSEcCtD
Fluocinonide—Skin disorder—Temozolomide—brain cancer	0.000234	0.00723	CcSEcCtD
Fluocinonide—Hypersensitivity—Hydroxyurea—brain cancer	0.000228	0.00702	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000225	0.00212	CbGpPWpGaD
Fluocinonide—Pain—Carmustine—brain cancer	0.000214	0.00659	CcSEcCtD
Fluocinonide—Pain—Temozolomide—brain cancer	0.000206	0.00637	CcSEcCtD
Fluocinonide—Dizziness—Hydroxyurea—brain cancer	0.000204	0.0063	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.0002	0.00617	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000199	0.00187	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000197	0.00185	CbGpPWpGaD
Fluocinonide—Rash—Hydroxyurea—brain cancer	0.000195	0.00601	CcSEcCtD
Fluocinonide—Dermatitis—Hydroxyurea—brain cancer	0.000195	0.006	CcSEcCtD
Fluocinonide—Headache—Hydroxyurea—brain cancer	0.000193	0.00597	CcSEcCtD
Fluocinonide—Infection—Etoposide—brain cancer	0.000192	0.00592	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—PTCH2—brain cancer	0.000191	0.00179	CbGpPWpGaD
Fluocinonide—Skin disorder—Etoposide—brain cancer	0.000188	0.00579	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—HES5—brain cancer	0.000185	0.00174	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Carmustine—brain cancer	0.000184	0.00567	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—STRADA—brain cancer	0.00018	0.00169	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Temozolomide—brain cancer	0.000178	0.00548	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000174	0.00163	CbGpPWpGaD
Fluocinonide—Pruritus—Temozolomide—brain cancer	0.000171	0.00527	CcSEcCtD
Fluocinonide—NR3C1—Endoderm Differentiation—APC—brain cancer	0.000168	0.00157	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—SHH—brain cancer	0.000167	0.00156	CbGpPWpGaD
Fluocinonide—Dizziness—Carmustine—brain cancer	0.000165	0.00509	CcSEcCtD
Fluocinonide—Pain—Etoposide—brain cancer	0.000165	0.00509	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—TRPC6—brain cancer	0.000161	0.00151	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.00016	0.0015	CbGpPWpGaD
Fluocinonide—Dizziness—Temozolomide—brain cancer	0.00016	0.00492	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—PTCH1—brain cancer	0.000158	0.00148	CbGpPWpGaD
Fluocinonide—Rash—Carmustine—brain cancer	0.000157	0.00486	CcSEcCtD
Fluocinonide—Dermatitis—Carmustine—brain cancer	0.000157	0.00485	CcSEcCtD
Fluocinonide—Headache—Carmustine—brain cancer	0.000156	0.00483	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000156	0.00147	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.000155	0.00145	CbGpPWpGaD
Fluocinonide—Rash—Temozolomide—brain cancer	0.000152	0.00469	CcSEcCtD
Fluocinonide—Dermatitis—Temozolomide—brain cancer	0.000152	0.00469	CcSEcCtD
Fluocinonide—Headache—Temozolomide—brain cancer	0.000151	0.00466	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—ESR2—brain cancer	0.00015	0.00141	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ABR—brain cancer	0.00015	0.00141	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GLI2—brain cancer	0.000145	0.00136	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Etoposide—brain cancer	0.000142	0.00439	CcSEcCtD
Fluocinonide—Pruritus—Etoposide—brain cancer	0.000137	0.00421	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—GLI1—brain cancer	0.000136	0.00128	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CDKN2A—brain cancer	0.000133	0.00125	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.000131	0.00123	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SUFU—brain cancer	0.000129	0.00121	CbGpPWpGaD
Fluocinonide—Dizziness—Etoposide—brain cancer	0.000128	0.00394	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—GFAP—brain cancer	0.000124	0.00117	CbGpPWpGaD
Fluocinonide—Rash—Etoposide—brain cancer	0.000122	0.00376	CcSEcCtD
Fluocinonide—Dermatitis—Etoposide—brain cancer	0.000122	0.00375	CcSEcCtD
Fluocinonide—Headache—Etoposide—brain cancer	0.000121	0.00373	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—VAV1—brain cancer	0.00012	0.00113	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HEY1—brain cancer	0.000118	0.00111	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HES1—brain cancer	0.000117	0.0011	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—DLL1—brain cancer	0.000116	0.00109	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL2—brain cancer	0.000115	0.00108	CbGpPWpGaD
Fluocinonide—NR3C1—Endoderm Differentiation—CTNNB1—brain cancer	0.000114	0.00107	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—IRS2—brain cancer	0.000113	0.00106	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—RELA—brain cancer	0.000113	0.00106	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CCND1—brain cancer	0.000112	0.00106	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CTNNB1—brain cancer	0.000111	0.00104	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—brain cancer	0.000102	0.000954	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SHH—brain cancer	9.84e-05	0.000924	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TRPC6—brain cancer	9.49e-05	0.000891	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PTCH1—brain cancer	9.33e-05	0.000876	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—MYC—brain cancer	9.01e-05	0.000846	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	8.02e-05	0.000753	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PIK3CG—brain cancer	7.64e-05	0.000718	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NOTCH2—brain cancer	7.46e-05	0.000701	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—TP53—brain cancer	7.4e-05	0.000695	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—VAV1—brain cancer	7.11e-05	0.000668	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—CTNNB1—brain cancer	6.78e-05	0.000637	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—brain cancer	6.52e-05	0.000612	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—ESR2—brain cancer	6.36e-05	0.000597	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HES1—brain cancer	6.11e-05	0.000574	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NOTCH2—brain cancer	6.02e-05	0.000565	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—STAT3—brain cancer	5.91e-05	0.000555	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	5.86e-05	0.00055	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PDGFRA—brain cancer	5.82e-05	0.000547	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SPP1—brain cancer	5.65e-05	0.000531	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—IL2—brain cancer	5.38e-05	0.000505	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—brain cancer	5.16e-05	0.000484	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IRS2—brain cancer	5.11e-05	0.00048	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CG—brain cancer	4.51e-05	0.000424	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—APC—brain cancer	4.51e-05	0.000424	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—EGFR—brain cancer	4.11e-05	0.000386	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—RELA—brain cancer	3.53e-05	0.000331	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ERBB2—brain cancer	3.51e-05	0.000329	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—DNMT1—brain cancer	3.41e-05	0.00032	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IL2—brain cancer	3.18e-05	0.000298	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCND1—brain cancer	3.1e-05	0.000291	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CTNNB1—brain cancer	3.07e-05	0.000288	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—ESR2—brain cancer	3.06e-05	0.000287	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NOTCH2—brain cancer	2.9e-05	0.000272	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—VEGFA—brain cancer	2.7e-05	0.000254	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—STAT3—brain cancer	2.67e-05	0.000251	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MYC—brain cancer	2.48e-05	0.000233	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—SIRT1—brain cancer	2.46e-05	0.000231	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—EGFR—brain cancer	2.43e-05	0.000228	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TP53—brain cancer	2.04e-05	0.000192	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—MYC—brain cancer	2e-05	0.000188	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—MYC—brain cancer	9.65e-06	9.07e-05	CbGpPWpGaD
